Nivolumab vs Topiramate

## Nivolumab vs Topiramate: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Topiramate**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Topiramate**: Multiple mechanisms: Na+ channel block, GABA enhancement, glutamate inhibition.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Topiramate — 21 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Topiramate — C12H21NO8S.

**Molecular Weight**: Nivolumab — N/A; Topiramate — 339.3630 g/mol.

**Type**: Nivolumab — Antibody; Topiramate — Small molecule.